Clinical Trials Browser

Phase 1 × Glioma × Lomustine × Clear all

Glioma

NCT01989052 2016-08-04

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Phase 1 Terminated

9 enrolled

CNSLymphoid

Glioma, Lymphoma, Follicular

NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Phase 1 Completed

10 enrolled

CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Clinical Trials

A Dose-Escalation Study in Participants With Recurrent Malignant Glioma

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors